Back to top
more

Argenx (ARGX)

(Real Time Quote from BATS)

$376.43 USD

376.43
235,602

+14.22 (3.93%)

Updated Apr 23, 2024 02:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ARGX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for argenex SE falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 2,049 801 1,335 1,133 371
Receivables 499 277 38 7 32
Notes Receivable 0 0 0 0 0
Inventories 311 228 109 23 0
Other Current Assets 1,265 1,468 1,061 752 1,135
Total Current Assets 4,124 2,774 2,543 1,915 1,538
Net Property & Equipment 23 16 16 11 9
Investments & Advances 10 1 0 0 0
Other Non-Current Assets 77 47 33 19 10
Deferred Charges 97 79 32 14 0
Intangibles 125 175 172 156 45
Deposits & Other Assets 87 41 55 7 4
Total Assets 4,542 3,134 2,850 2,122 1,605
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 414 296 293 256 96
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 4 3 4 3 0
Other Current Liabilities 0 0 0 43 81
Total Current Liabilities 423 302 301 306 179
Mortgages 0 0 0 0 0
Deferred Taxes/Income 5 8 6 252 244
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 1 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 445 321 316 564 429
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 7 7 6 5 5
Capital Surplus 5,652 4,310 3,463 2,351 1,466
Retained Earnings -2,405 -2,110 -1,400 -984 -372
Other Equity 844 607 465 186 79
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 4,098 2,814 2,534 1,559 1,177
Total Liabilities & Shareholder's Equity 4,542 3,134 2,850 2,122 1,605
Total Common Equity 4,098 2,814 2,534 1,559 1,177
Shares Outstanding 59.10 55.40 51.60 47.30 38.10
Book Value Per Share 69.33 50.79 49.11 32.95 30.89

Fiscal Year End for argenex SE falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 2,049 0 1,111 0
Receivables NA 499 0 355 0
Notes Receivable NA 0 0 0 0
Inventories NA 311 0 201 0
Other Current Assets NA 1,265 0 1,025 0
Total Current Assets NA 4,124 0 2,692 0
Net Property & Equipment NA 23 0 15 0
Investments & Advances NA 10 0 12 0
Other Non-Current Assets NA 77 0 60 0
Deferred Charges NA 97 0 139 0
Intangibles NA 125 0 190 0
Deposits & Other Assets NA 87 0 87 0
Total Assets NA 4,542 0 3,194 0
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 414 0 310 0
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 4 0 5 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 423 0 318 0
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 5 0 9 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 0 1 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 445 0 336 0
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 7 0 7 0
Capital Surplus NA 5,652 0 4,374 0
Retained Earnings NA -2,405 0 -2,233 0
Other Equity NA 844 0 710 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 4,098 0 2,858 0
Total Liabilities & Shareholder's Equity NA 4,542 0 3,194 0
Total Common Equity 0 4,098 0 2,858 0
Shares Outstanding 59.30 59.10 59.00 57.80 55.60
Book Value Per Share 0.00 69.33 0.00 49.45 0.00